(Q39946483)

15 September 2017

title

Molecular diversity at the CYP2D6 locus in healthy and schizophrenic southern Brazilians (English)

1 reference

15 September 2017

0 references

8

1 reference

15 September 2017

Paulo Belmonte-de-Abreu

Paulo Belmonte-de-Abreu

4

0 references

Francisco Barros

Francisco Barros

6

0 references

Maria Inês Lobato

Maria Inês Lobato

3

0 references

Clarissa Severino Gama

2

Clarissa S Gama

1 reference

15 September 2017

7

Angel Carracedo

1 reference

15 September 2017

1

Fabiana B Kohlrausch

1 reference

15 September 2017

5

Alejandro Gesteira

1 reference

15 September 2017

publication date

1 September 2009

1 reference

15 September 2017

number of pages

10

1 reference

based on heuristic

inferred from page(s)

published in

Pharmacogenomics

1 reference

15 September 2017

volume

10

1 reference

15 September 2017

issue

9

1 reference

15 September 2017

page(s)

1457-1466

1 reference

Clinical importance of the cytochromes P450

15 September 2017

cites work

1 reference

Pharmacogenetics of drug-metabolizing enzymes: implications for a safer and more effective drug therapy

21 January 2018

1 reference

Potential role of pharmacogenomics in reducing adverse drug reactions: a systematic review

21 January 2018

1 reference

CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants

21 January 2018

1 reference

AmpliChip CYP450 test: personalized medicine has arrived in psychiatry.

21 January 2018

1 reference

Pharmacogenetics of debrisoquine and its use as a marker for CYP2D6 hydroxylation capacity.

21 January 2018

1 reference

Cellular localization and regional distribution of CYP2D6 mRNA and protein expression in human brain

21 January 2018

1 reference

21 January 2018

1 reference

The impact of the CYP2D6 polymorphism on haloperidol pharmacokinetics and on the outcome of haloperidol treatment.

21 January 2018

1 reference

No association between schizophrenia and polymorphisms within the genes for debrisoquine 4-hydroxylase (CYP2D6) and the dopamine transporter (DAT).

21 January 2018

1 reference

Debrisoquine 4-hydroxylase (CYP2D6) genetic polymorphisms and susceptibility to schizophrenia in Chinese patients from Taiwan

21 January 2018

1 reference

Naturalistic pharmacogenetic study of treatment resistance to typical neuroleptics in European-Brazilian schizophrenics

21 January 2018

1 reference

Genetic variability in two Brazilian ethnic groups: a comparison of mitochondrial and protein data

21 January 2018

1 reference

Genetics, surnames, grandparents' nationalities, and ethnic admixture in Southern Brazil: Do the patterns of variation coincide?

21 January 2018

1 reference

A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies

21 January 2018

1 reference

Historical genetics: spatiotemporal analysis of the formation of the Brazilian population

21 January 2018

1 reference

Genetic polymorphism of drug metabolising enzymes in African populations: implications for the use of neuroleptics and antidepressants

21 January 2018

1 reference

Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity

21 January 2018

1 reference

Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquine

21 January 2018

1 reference

Pharmacogenetic testing in psychiatry: a review of features and clinical realities.

21 January 2018

1 reference

Pharmacogenetics of the cytochromes P450.

21 January 2018

1 reference

CYP2D6 polymorphism: implications for antipsychotic drug response, schizophrenia and personality traits

21 January 2018

1 reference

The future (or lack of future) of personalized prescription in psychiatry.

21 January 2018

1 reference

Clinical pharmacogenetics and potential application in personalized medicine

21 January 2018

1 reference

Pharmacogenomics in the Americas: the impact of genetic admixture.

21 January 2018

1 reference

Lack of association between schizophrenia and theCYPZD6 gene polymorphisms

21 January 2018

1 reference

Low frequency of CYP2D6 poor metabolizers among schizophrenia patients

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/PGS.09.76

1 reference

15 September 2017

1 reference